Theracys Powder For Bladder Irrigation 81Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Theracys: Powder for bladder irrigation (81mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

BACILLUS CALMETTE-GUERIN LIVE, BCG (ba SIL us KAL met gay RAYN) is a bacteria solution. This medicine stimulates the immune system to ward off cancer cells. It is used to treat bladder cancer.

In-Depth Information

Theracys 81mg Powder for Bladder Irrigation

NDC: 492810880
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Bladder Cancer

Storage Information
Refrigerate (between 36 and 46 degrees F)
Theracys 81mg Powder for Bladder Irrigation

Reported Side Effects for Theracys 81mg Powder for Bladder Irrigation

Upset Stomach Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Bladder Discomfort Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Weight Loss Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Skin Rash Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Pus In Urine Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Feeling Sick Incidence:
<2.0%*
Severity: SEVERE
Onset: EARLY
Back Pain Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Liver Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Coagulopathy Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Urinary Urgency Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Low Platelet Count Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Prostate Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Lung Inflammation Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Epididymis Inflammation Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Muscle Pain Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Loose Stools Incidence:
<6.0%*
Severity: MILD
Onset: EARLY
Decreased Appetite Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Tired Incidence:
<7.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Bladder Infection Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Nighttime Urination Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Joint Pain Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Stomach Pain Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Uncontrolled Urination Incidence:
2.0-6.0%*
Severity: MODERATE
Onset: EARLY
Increased Urination Incidence:
2.0-7.0%*
Severity: SEVERE
Onset: EARLY
Diaphoresis Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Chills Incidence:
3.0%*
Severity: SEVERE
Onset: RAPID
Fever Incidence:
3.0-8.0%*
Severity: SEVERE
Onset: EARLY
Painful Urination Incidence:
4.0-11.0%*
Severity: SEVERE
Onset: EARLY
Low White Blood Cell Counts Incidence:
5.0%*
Severity: MODERATE
Onset: DELAYED
Blood In The Urine Incidence:
7.0%*
Severity: SEVERE
Onset: DELAYED
Painful Bloody Urine Incidence:
9.0%*
Severity: SEVERE
Onset: DELAYED
Anemia Incidence:
21.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Theracys

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5